Form 8-K - Current report:
SEC Accession No. 0001437749-23-022895
Filing Date
2023-08-10
Accepted
2023-08-10 09:45:02
Documents
15
Period of Report
2023-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20230809_8k.htm   iXBRL 8-K 27219
2 EXHIBIT 99.1 ex_557810.htm EX-99.1 88490
7 logo01.jpg GRAPHIC 13993
  Complete submission text file 0001437749-23-022895.txt   297131

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20230809.xsd EX-101.SCH 3890
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20230809_def.xml EX-101.DEF 13442
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20230809_lab.xml EX-101.LAB 17669
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20230809_pre.xml EX-101.PRE 13419
9 EXTRACTED XBRL INSTANCE DOCUMENT govx20230809_8k_htm.xml XML 4397
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 231157602
SIC: 2834 Pharmaceutical Preparations